Annual EBITDA
-$11.71 M
+$14.46 M+55.25%
December 31, 2022
Summary
- As of February 8, 2025, SCPS annual EBITDA is -$11.71 million, with the most recent change of +$14.46 million (+55.25%) on December 31, 2022.
- During the last 3 years, SCPS annual EBITDA has fallen by -$9.02 million (-335.54%).
- SCPS annual EBITDA is now -1607.45% below its all-time high of -$686.00 thousand, reached on December 31, 2018.
Performance
SCPS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.93 M
-$249.10 K-9.30%
June 30, 2023
Summary
- As of February 8, 2025, SCPS quarterly EBITDA is -$2.93 million, with the most recent change of -$249.10 thousand (-9.30%) on June 30, 2023.
- Over the past year, SCPS quarterly EBITDA has dropped by -$1.03 million (-54.27%).
- SCPS quarterly EBITDA is now -2290.61% below its all-time high of -$122.50 thousand, reached on March 1, 2018.
Performance
SCPS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$9.34 M
+$390.50 K+4.01%
June 30, 2023
Summary
- As of February 8, 2025, SCPS TTM EBITDA is -$9.34 million, with the most recent change of +$390.50 thousand (+4.01%) on June 30, 2023.
- Over the past year, SCPS TTM EBITDA has increased by +$7.05 million (+43.02%).
- SCPS TTM EBITDA is now -7526.04% below its all-time high of -$122.50 thousand, reached on March 1, 2018.
Performance
SCPS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SCPS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.3% | -54.3% | +43.0% |
| 3 y3 years | -335.5% | +63.1% | +9.5% |
| 5 y5 years | - | -1824.1% | -247.4% |
SCPS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.3% | -59.5% | +55.1% | at high | +66.3% |
| 5 y | 5-year | -335.5% | +55.3% | -373.2% | +80.9% | -247.4% | +66.3% |
| alltime | all time | -1607.5% | +55.3% | -2290.6% | +80.9% | -7526.0% | +66.3% |
Scopus BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.93 M(+9.3%) | -$9.34 M(-4.0%) |
| Mar 2023 | - | -$2.68 M(+46.0%) | -$9.73 M(-16.9%) |
| Dec 2022 | -$11.71 M(-55.3%) | -$1.84 M(-3.3%) | -$11.71 M(-28.6%) |
| Sep 2022 | - | -$1.90 M(-42.8%) | -$16.40 M(+3.9%) |
| Jun 2022 | - | -$3.32 M(-28.8%) | -$15.79 M(-43.1%) |
| Mar 2022 | - | -$4.66 M(-28.5%) | -$27.76 M(+6.1%) |
| Dec 2021 | -$26.18 M(+157.8%) | -$6.52 M(+405.6%) | -$26.18 M(+28.5%) |
| Sep 2021 | - | -$1.29 M(-91.6%) | -$20.37 M(+2.1%) |
| Jun 2021 | - | -$15.30 M(+397.8%) | -$19.96 M(+58.3%) |
| Mar 2021 | - | -$3.07 M(+330.5%) | -$12.61 M(+24.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$10.15 M(+277.6%) | -$713.80 K(-18.4%) | -$10.15 M(-2.4%) |
| Sep 2020 | - | -$875.10 K(-89.0%) | -$10.40 M(+0.8%) |
| Jun 2020 | - | -$7.95 M(+1183.7%) | -$10.32 M(+266.6%) |
| Mar 2020 | - | -$618.90 K(-35.8%) | -$2.82 M(+4.7%) |
| Dec 2019 | -$2.69 M(+292.0%) | -$963.30 K(+20.8%) | -$2.69 M(+55.8%) |
| Sep 2019 | - | -$797.20 K(+82.3%) | -$1.73 M(+85.8%) |
| Jun 2019 | - | -$437.20 K(-11.1%) | -$928.90 K(+44.3%) |
| Mar 2019 | - | -$491.70 K(+223.1%) | -$643.90 K(+134.4%) |
| Dec 2018 | -$686.00 K | - | - |
| Jun 2018 | - | -$152.20 K(+24.2%) | -$274.70 K(+124.2%) |
| Mar 2018 | - | -$122.50 K | -$122.50 K |
FAQ
- What is Scopus BioPharma annual EBITDA?
- What is the all time high annual EBITDA for Scopus BioPharma?
- What is Scopus BioPharma annual EBITDA year-on-year change?
- What is Scopus BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Scopus BioPharma?
- What is Scopus BioPharma quarterly EBITDA year-on-year change?
- What is Scopus BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for Scopus BioPharma?
- What is Scopus BioPharma TTM EBITDA year-on-year change?
What is Scopus BioPharma annual EBITDA?
The current annual EBITDA of SCPS is -$11.71 M
What is the all time high annual EBITDA for Scopus BioPharma?
Scopus BioPharma all-time high annual EBITDA is -$686.00 K
What is Scopus BioPharma annual EBITDA year-on-year change?
Over the past year, SCPS annual EBITDA has changed by +$14.46 M (+55.25%)
What is Scopus BioPharma quarterly EBITDA?
The current quarterly EBITDA of SCPS is -$2.93 M
What is the all time high quarterly EBITDA for Scopus BioPharma?
Scopus BioPharma all-time high quarterly EBITDA is -$122.50 K
What is Scopus BioPharma quarterly EBITDA year-on-year change?
Over the past year, SCPS quarterly EBITDA has changed by -$1.03 M (-54.27%)
What is Scopus BioPharma TTM EBITDA?
The current TTM EBITDA of SCPS is -$9.34 M
What is the all time high TTM EBITDA for Scopus BioPharma?
Scopus BioPharma all-time high TTM EBITDA is -$122.50 K
What is Scopus BioPharma TTM EBITDA year-on-year change?
Over the past year, SCPS TTM EBITDA has changed by +$7.05 M (+43.02%)